The global Therapeutic Cancer Vaccines market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.

The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

This report aims to provide a comprehensive presentation of the global market for Therapeutic Cancer Vaccines, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Therapeutic Cancer Vaccines.

Report Scope

The Therapeutic Cancer Vaccines market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Therapeutic Cancer Vaccines market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Therapeutic Cancer Vaccines manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Scope of Therapeutic Cancer Vaccines Market Report

Report Metric	Details
Report Name	Therapeutic Cancer Vaccines Market
CAGR	5%
Segment by Type	Whole Cell Vaccine Antigen Vaccine Non-specific and Cytokine Strategies Others
Segment by Application	Bladder Cancer Brain Tumors Breast Cancer Lung Cancer Prostate Cancer Cervical Cancer Others
Consumption by Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Asia-Pacific (China, Japan, South Korea, Taiwan) Southeast Asia (India) Latin America (Mexico, Brazil)
By Company	Antigenics, Asterias Biotherapeutics, Avax Technologies, Bayer, GlaxoSmithKline, Mayo Clinic, Merck, Moderna, Northwest Biotherapeutics, VAXIMM
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Therapeutic Cancer Vaccines manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Therapeutic Cancer Vaccines in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Therapeutic Cancer Vaccines Market report?

Ans: The main players in the Therapeutic Cancer Vaccines Market are Antigenics, Asterias Biotherapeutics, Avax Technologies, Bayer, GlaxoSmithKline, Mayo Clinic, Merck, Moderna, Northwest Biotherapeutics, VAXIMM

What are the Application segmentation covered in the Therapeutic Cancer Vaccines Market report?

Ans: The Applications covered in the Therapeutic Cancer Vaccines Market report are Bladder Cancer, Brain Tumors, Breast Cancer, Lung Cancer, Prostate Cancer, Cervical Cancer, Others

What are the Type segmentation covered in the Therapeutic Cancer Vaccines Market report?

Ans: The Types covered in the Therapeutic Cancer Vaccines Market report are Whole Cell Vaccine, Antigen Vaccine, Non-specific and Cytokine Strategies, Others

1 Therapeutic Cancer Vaccines Market Overview

1.1 Product Overview and Scope of Therapeutic Cancer Vaccines

1.2 Therapeutic Cancer Vaccines Segment by Type

1.2.1 Global Therapeutic Cancer Vaccines Market Value Comparison by Type (2024-2030)

1.2.2 Whole Cell Vaccine

1.2.3 Antigen Vaccine

1.2.4 Non-specific and Cytokine Strategies

1.2.5 Others

1.3 Therapeutic Cancer Vaccines Segment by Application

1.3.1 Global Therapeutic Cancer Vaccines Market Value by Application: (2024-2030)

1.3.2 Bladder Cancer

1.3.3 Brain Tumors

1.3.4 Breast Cancer

1.3.5 Lung Cancer

1.3.6 Prostate Cancer

1.3.7 Cervical Cancer

1.3.8 Others

1.4 Global Therapeutic Cancer Vaccines Market Size Estimates and Forecasts

1.4.1 Global Therapeutic Cancer Vaccines Revenue 2019-2030

1.4.2 Global Therapeutic Cancer Vaccines Sales 2019-2030

1.4.3 Global Therapeutic Cancer Vaccines Market Average Price (2019-2030)

1.5 Assumptions and Limitations

2 Therapeutic Cancer Vaccines Market Competition by Manufacturers

2.1 Global Therapeutic Cancer Vaccines Sales Market Share by Manufacturers (2019-2024)

2.2 Global Therapeutic Cancer Vaccines Revenue Market Share by Manufacturers (2019-2024)

2.3 Global Therapeutic Cancer Vaccines Average Price by Manufacturers (2019-2024)

2.4 Global Therapeutic Cancer Vaccines Industry Ranking 2022 VS 2023 VS 2024

2.5 Global Key Manufacturers of Therapeutic Cancer Vaccines, Manufacturing Sites & Headquarters

2.6 Global Key Manufacturers of Therapeutic Cancer Vaccines, Product Type & Application

2.7 Therapeutic Cancer Vaccines Market Competitive Situation and Trends

2.7.1 Therapeutic Cancer Vaccines Market Concentration Rate

2.7.2 The Global Top 5 and Top 10 Largest Therapeutic Cancer Vaccines Players Market Share by Revenue

2.7.3 Global Therapeutic Cancer Vaccines Market Share by Company Type (Tier 1, Tier 2 and Tier 3)

2.8 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Therapeutic Cancer Vaccines Retrospective Market Scenario by Region

3.1 Global Therapeutic Cancer Vaccines Market Size by Region: 2019 Versus 2023 Versus 2030

3.2 Global Therapeutic Cancer Vaccines Global Therapeutic Cancer Vaccines Sales by Region: 2019-2030

3.2.1 Global Therapeutic Cancer Vaccines Sales by Region: 2019-2024

3.2.2 Global Therapeutic Cancer Vaccines Sales by Region: 2025-2030

3.3 Global Therapeutic Cancer Vaccines Global Therapeutic Cancer Vaccines Revenue by Region: 2019-2030

3.3.1 Global Therapeutic Cancer Vaccines Revenue by Region: 2019-2024

3.3.2 Global Therapeutic Cancer Vaccines Revenue by Region: 2025-2030

3.4 North America Therapeutic Cancer Vaccines Market Facts & Figures by Country

3.4.1 North America Therapeutic Cancer Vaccines Market Size by Country: 2019 VS 2023 VS 2030

3.4.2 North America Therapeutic Cancer Vaccines Sales by Country (2019-2030)

3.4.3 North America Therapeutic Cancer Vaccines Revenue by Country (2019-2030)

3.4.4 U.S.

3.4.5 Canada

3.5 Europe Therapeutic Cancer Vaccines Market Facts & Figures by Country

3.5.1 Europe Therapeutic Cancer Vaccines Market Size by Country: 2019 VS 2023 VS 2030

3.5.2 Europe Therapeutic Cancer Vaccines Sales by Country (2019-2030)

3.5.3 Europe Therapeutic Cancer Vaccines Revenue by Country (2019-2030)

3.5.4 Germany

3.5.5 France

3.5.6 U.K.

3.5.7 Italy

3.5.8 Russia

3.6 Asia Pacific Therapeutic Cancer Vaccines Market Facts & Figures by Country

3.6.1 Asia Pacific Therapeutic Cancer Vaccines Market Size by Country: 2019 VS 2023 VS 2030

3.6.2 Asia Pacific Therapeutic Cancer Vaccines Sales by Country (2019-2030)

3.6.3 Asia Pacific Therapeutic Cancer Vaccines Revenue by Country (2019-2030)

3.6.4 China

3.6.5 Japan

3.6.6 South Korea

3.6.7 India

3.6.8 Australia

3.6.9 Taiwan

3.6.10 Indonesia

3.6.11 Thailand

3.6.12 Malaysia

3.6.13 Philippines

3.7 Latin America Therapeutic Cancer Vaccines Market Facts & Figures by Country

3.7.1 Latin America Therapeutic Cancer Vaccines Market Size by Country: 2019 VS 2023 VS 2030

3.7.2 Latin America Therapeutic Cancer Vaccines Sales by Country (2019-2030)

3.7.3 Latin America Therapeutic Cancer Vaccines Revenue by Country (2019-2030)

3.7.4 Mexico

3.7.5 Brazil

3.7.6 Argentina

3.8 Middle East and Africa Therapeutic Cancer Vaccines Market Facts & Figures by Country

3.8.1 Middle East and Africa Therapeutic Cancer Vaccines Market Size by Country: 2019 VS 2023 VS 2030

3.8.2 Middle East and Africa Therapeutic Cancer Vaccines Sales by Country (2019-2030)

3.8.3 Middle East and Africa Therapeutic Cancer Vaccines Revenue by Country (2019-2030)

3.8.4 Turkey

3.8.5 Saudi Arabia

3.8.6 UAE

4 Segment by Type

4.1 Global Therapeutic Cancer Vaccines Sales by Type (2019-2030)

4.1.1 Global Therapeutic Cancer Vaccines Sales by Type (2019-2024)

4.1.2 Global Therapeutic Cancer Vaccines Sales by Type (2025-2030)

4.1.3 Global Therapeutic Cancer Vaccines Sales Market Share by Type (2019-2030)

4.2 Global Therapeutic Cancer Vaccines Revenue by Type (2019-2030)

4.2.1 Global Therapeutic Cancer Vaccines Revenue by Type (2019-2024)

4.2.2 Global Therapeutic Cancer Vaccines Revenue by Type (2025-2030)

4.2.3 Global Therapeutic Cancer Vaccines Revenue Market Share by Type (2019-2030)

4.3 Global Therapeutic Cancer Vaccines Price by Type (2019-2030)

5 Segment by Application

5.1 Global Therapeutic Cancer Vaccines Sales by Application (2019-2030)

5.1.1 Global Therapeutic Cancer Vaccines Sales by Application (2019-2024)

5.1.2 Global Therapeutic Cancer Vaccines Sales by Application (2025-2030)

5.1.3 Global Therapeutic Cancer Vaccines Sales Market Share by Application (2019-2030)

5.2 Global Therapeutic Cancer Vaccines Revenue by Application (2019-2030)

5.2.1 Global Therapeutic Cancer Vaccines Revenue by Application (2019-2024)

5.2.2 Global Therapeutic Cancer Vaccines Revenue by Application (2025-2030)

5.2.3 Global Therapeutic Cancer Vaccines Revenue Market Share by Application (2019-2030)

5.3 Global Therapeutic Cancer Vaccines Price by Application (2019-2030)

6 Key Companies Profiled

6.1 Antigenics

6.1.1 Antigenics Corporation Information

6.1.2 Antigenics Description and Business Overview

6.1.3 Antigenics Therapeutic Cancer Vaccines Sales, Revenue and Gross Margin (2019-2024)

6.1.4 Antigenics Therapeutic Cancer Vaccines Product Portfolio

6.1.5 Antigenics Recent Developments/Updates

6.2 Asterias Biotherapeutics

6.2.1 Asterias Biotherapeutics Corporation Information

6.2.2 Asterias Biotherapeutics Description and Business Overview

6.2.3 Asterias Biotherapeutics Therapeutic Cancer Vaccines Sales, Revenue and Gross Margin (2019-2024)

6.2.4 Asterias Biotherapeutics Therapeutic Cancer Vaccines Product Portfolio

6.2.5 Asterias Biotherapeutics Recent Developments/Updates

6.3 Avax Technologies

6.3.1 Avax Technologies Corporation Information

6.3.2 Avax Technologies Description and Business Overview

6.3.3 Avax Technologies Therapeutic Cancer Vaccines Sales, Revenue and Gross Margin (2019-2024)

6.3.4 Avax Technologies Therapeutic Cancer Vaccines Product Portfolio

6.3.5 Avax Technologies Recent Developments/Updates

6.4 Bayer

6.4.1 Bayer Corporation Information

6.4.2 Bayer Description and Business Overview

6.4.3 Bayer Therapeutic Cancer Vaccines Sales, Revenue and Gross Margin (2019-2024)

6.4.4 Bayer Therapeutic Cancer Vaccines Product Portfolio

6.4.5 Bayer Recent Developments/Updates

6.5 GlaxoSmithKline

6.5.1 GlaxoSmithKline Corporation Information

6.5.2 GlaxoSmithKline Description and Business Overview

6.5.3 GlaxoSmithKline Therapeutic Cancer Vaccines Sales, Revenue and Gross Margin (2019-2024)

6.5.4 GlaxoSmithKline Therapeutic Cancer Vaccines Product Portfolio

6.5.5 GlaxoSmithKline Recent Developments/Updates

6.6 Mayo Clinic

6.6.1 Mayo Clinic Corporation Information

6.6.2 Mayo Clinic Description and Business Overview

6.6.3 Mayo Clinic Therapeutic Cancer Vaccines Sales, Revenue and Gross Margin (2019-2024)

6.6.4 Mayo Clinic Therapeutic Cancer Vaccines Product Portfolio

6.6.5 Mayo Clinic Recent Developments/Updates

6.7 Merck

6.6.1 Merck Corporation Information

6.6.2 Merck Description and Business Overview

6.6.3 Merck Therapeutic Cancer Vaccines Sales, Revenue and Gross Margin (2019-2024)

6.4.4 Merck Therapeutic Cancer Vaccines Product Portfolio

6.7.5 Merck Recent Developments/Updates

6.8 Moderna

6.8.1 Moderna Corporation Information

6.8.2 Moderna Description and Business Overview

6.8.3 Moderna Therapeutic Cancer Vaccines Sales, Revenue and Gross Margin (2019-2024)

6.8.4 Moderna Therapeutic Cancer Vaccines Product Portfolio

6.8.5 Moderna Recent Developments/Updates

6.9 Northwest Biotherapeutics

6.9.1 Northwest Biotherapeutics Corporation Information

6.9.2 Northwest Biotherapeutics Description and Business Overview

6.9.3 Northwest Biotherapeutics Therapeutic Cancer Vaccines Sales, Revenue and Gross Margin (2019-2024)

6.9.4 Northwest Biotherapeutics Therapeutic Cancer Vaccines Product Portfolio

6.9.5 Northwest Biotherapeutics Recent Developments/Updates

6.10 VAXIMM

6.10.1 VAXIMM Corporation Information

6.10.2 VAXIMM Description and Business Overview

6.10.3 VAXIMM Therapeutic Cancer Vaccines Sales, Revenue and Gross Margin (2019-2024)

6.10.4 VAXIMM Therapeutic Cancer Vaccines Product Portfolio

6.10.5 VAXIMM Recent Developments/Updates

7 Industry Chain and Sales Channels Analysis

7.1 Therapeutic Cancer Vaccines Industry Chain Analysis

7.2 Therapeutic Cancer Vaccines Key Raw Materials

7.2.1 Key Raw Materials

7.2.2 Raw Materials Key Suppliers

7.3 Therapeutic Cancer Vaccines Production Mode & Process

7.4 Therapeutic Cancer Vaccines Sales and Marketing

7.4.1 Therapeutic Cancer Vaccines Sales Channels

7.4.2 Therapeutic Cancer Vaccines Distributors

7.5 Therapeutic Cancer Vaccines Customers

8 Therapeutic Cancer Vaccines Market Dynamics

8.1 Therapeutic Cancer Vaccines Industry Trends

8.2 Therapeutic Cancer Vaccines Market Drivers

8.3 Therapeutic Cancer Vaccines Market Challenges

8.4 Therapeutic Cancer Vaccines Market Restraints

9 Research Finding and Conclusion

10 Methodology and Data Source

10.1 Methodology/Research Approach

10.1.1 Research Programs/Design

10.1.2 Market Size Estimation

10.1.3 Market Breakdown and Data Triangulation

10.2 Data Source

10.2.1 Secondary Sources

10.2.2 Primary Sources

10.3 Author List

10.4 Disclaimer

FEATURED COMPANIES

Antigenics

Asterias Biotherapeutics

Northwest Biotherapeutics

Vaximm AG

List of Tables

Table 1. Global Therapeutic Cancer Vaccines Market Value Comparison by Type (2024-2030) & (US$ Million)

Table 2. Global Therapeutic Cancer Vaccines Market Value Comparison by Application (2024-2030) & (US$ Million)

Table 3. Global Therapeutic Cancer Vaccines Market Competitive Situation by Manufacturers in 2023

Table 4. Global Therapeutic Cancer Vaccines Sales (K Units) of Key Manufacturers (2019-2024)

Table 5. Global Therapeutic Cancer Vaccines Sales Market Share by Manufacturers (2019-2024)

Table 6. Global Therapeutic Cancer Vaccines Revenue (US$ Million) by Manufacturers (2019-2024)

Table 7. Global Therapeutic Cancer Vaccines Revenue Share by Manufacturers (2019-2024)

Table 8. Global Market Therapeutic Cancer Vaccines Average Price (US$/Unit) of Key Manufacturers (2019-2024)

Table 9. Global Key Players of Therapeutic Cancer Vaccines, Industry Ranking, 2022 VS 2023 VS 2024

Table 10. Global Key Manufacturers of Therapeutic Cancer Vaccines, Manufacturing Sites & Headquarters

Table 11. Global Key Manufacturers of Therapeutic Cancer Vaccines, Product Type & Application

Table 12. Global Key Manufacturers of Therapeutic Cancer Vaccines, Date of Enter into This Industry

Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 14. Global Therapeutic Cancer Vaccines by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Therapeutic Cancer Vaccines as of 2023)

Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans

Table 16. Global Therapeutic Cancer Vaccines Market Size by Region (US$ Million): 2019 VS 2023 VS 2030

Table 17. Global Therapeutic Cancer Vaccines Sales by Region (2019-2024) & (K Units)

Table 18. Global Therapeutic Cancer Vaccines Sales Market Share by Region (2019-2024)

Table 19. Global Therapeutic Cancer Vaccines Sales by Region (2025-2030) & (K Units)

Table 20. Global Therapeutic Cancer Vaccines Sales Market Share by Region (2025-2030)

Table 21. Global Therapeutic Cancer Vaccines Revenue by Region (2019-2024) & (US$ Million)

Table 22. Global Therapeutic Cancer Vaccines Revenue Market Share by Region (2019-2024)

Table 23. Global Therapeutic Cancer Vaccines Revenue by Region (2025-2030) & (US$ Million)

Table 24. Global Therapeutic Cancer Vaccines Revenue Market Share by Region (2025-2030)

Table 25. North America Therapeutic Cancer Vaccines Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 26. North America Therapeutic Cancer Vaccines Sales by Country (2019-2024) & (K Units)

Table 27. North America Therapeutic Cancer Vaccines Sales by Country (2025-2030) & (K Units)

Table 28. North America Therapeutic Cancer Vaccines Revenue by Country (2019-2024) & (US$ Million)

Table 29. North America Therapeutic Cancer Vaccines Revenue by Country (2025-2030) & (US$ Million)

Table 30. Europe Therapeutic Cancer Vaccines Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 31. Europe Therapeutic Cancer Vaccines Sales by Country (2019-2024) & (K Units)

Table 32. Europe Therapeutic Cancer Vaccines Sales by Country (2025-2030) & (K Units)

Table 33. Europe Therapeutic Cancer Vaccines Revenue by Country (2019-2024) & (US$ Million)

Table 34. Europe Therapeutic Cancer Vaccines Revenue by Country (2025-2030) & (US$ Million)

Table 35. Asia Pacific Therapeutic Cancer Vaccines Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)

Table 36. Asia Pacific Therapeutic Cancer Vaccines Sales by Region (2019-2024) & (K Units)

Table 37. Asia Pacific Therapeutic Cancer Vaccines Sales by Region (2025-2030) & (K Units)

Table 38. Asia Pacific Therapeutic Cancer Vaccines Revenue by Region (2019-2024) & (US$ Million)

Table 39. Asia Pacific Therapeutic Cancer Vaccines Revenue by Region (2025-2030) & (US$ Million)

Table 40. Latin America Therapeutic Cancer Vaccines Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 41. Latin America Therapeutic Cancer Vaccines Sales by Country (2019-2024) & (K Units)

Table 42. Latin America Therapeutic Cancer Vaccines Sales by Country (2025-2030) & (K Units)

Table 43. Latin America Therapeutic Cancer Vaccines Revenue by Country (2019-2024) & (US$ Million)

Table 44. Latin America Therapeutic Cancer Vaccines Revenue by Country (2025-2030) & (US$ Million)

Table 45. Middle East & Africa Therapeutic Cancer Vaccines Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 46. Middle East & Africa Therapeutic Cancer Vaccines Sales by Country (2019-2024) & (K Units)

Table 47. Middle East & Africa Therapeutic Cancer Vaccines Sales by Country (2025-2030) & (K Units)

Table 48. Middle East & Africa Therapeutic Cancer Vaccines Revenue by Country (2019-2024) & (US$ Million)

Table 49. Middle East & Africa Therapeutic Cancer Vaccines Revenue by Country (2025-2030) & (US$ Million)

Table 50. Global Therapeutic Cancer Vaccines Sales (K Units) by Type (2019-2024)

Table 51. Global Therapeutic Cancer Vaccines Sales (K Units) by Type (2025-2030)

Table 52. Global Therapeutic Cancer Vaccines Sales Market Share by Type (2019-2024)

Table 53. Global Therapeutic Cancer Vaccines Sales Market Share by Type (2025-2030)

Table 54. Global Therapeutic Cancer Vaccines Revenue (US$ Million) by Type (2019-2024)

Table 55. Global Therapeutic Cancer Vaccines Revenue (US$ Million) by Type (2025-2030)

Table 56. Global Therapeutic Cancer Vaccines Revenue Market Share by Type (2019-2024)

Table 57. Global Therapeutic Cancer Vaccines Revenue Market Share by Type (2025-2030)

Table 58. Global Therapeutic Cancer Vaccines Price (US$/Unit) by Type (2019-2024)

Table 59. Global Therapeutic Cancer Vaccines Price (US$/Unit) by Type (2025-2030)

Table 60. Global Therapeutic Cancer Vaccines Sales (K Units) by Application (2019-2024)

Table 61. Global Therapeutic Cancer Vaccines Sales (K Units) by Application (2025-2030)

Table 62. Global Therapeutic Cancer Vaccines Sales Market Share by Application (2019-2024)

Table 63. Global Therapeutic Cancer Vaccines Sales Market Share by Application (2025-2030)

Table 64. Global Therapeutic Cancer Vaccines Revenue (US$ Million) by Application (2019-2024)

Table 65. Global Therapeutic Cancer Vaccines Revenue (US$ Million) by Application (2025-2030)

Table 66. Global Therapeutic Cancer Vaccines Revenue Market Share by Application (2019-2024)

Table 67. Global Therapeutic Cancer Vaccines Revenue Market Share by Application (2025-2030)

Table 68. Global Therapeutic Cancer Vaccines Price (US$/Unit) by Application (2019-2024)

Table 69. Global Therapeutic Cancer Vaccines Price (US$/Unit) by Application (2025-2030)

Table 70. Antigenics Corporation Information

Table 71. Antigenics Description and Business Overview

Table 72. Antigenics Therapeutic Cancer Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 73. Antigenics Therapeutic Cancer Vaccines Product

Table 74. Antigenics Recent Developments/Updates

Table 75. Asterias Biotherapeutics Corporation Information

Table 76. Asterias Biotherapeutics Description and Business Overview

Table 77. Asterias Biotherapeutics Therapeutic Cancer Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 78. Asterias Biotherapeutics Therapeutic Cancer Vaccines Product

Table 79. Asterias Biotherapeutics Recent Developments/Updates

Table 80. Avax Technologies Corporation Information

Table 81. Avax Technologies Description and Business Overview

Table 82. Avax Technologies Therapeutic Cancer Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 83. Avax Technologies Therapeutic Cancer Vaccines Product

Table 84. Avax Technologies Recent Developments/Updates

Table 85. Bayer Corporation Information

Table 86. Bayer Description and Business Overview

Table 87. Bayer Therapeutic Cancer Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 88. Bayer Therapeutic Cancer Vaccines Product

Table 89. Bayer Recent Developments/Updates

Table 90. GlaxoSmithKline Corporation Information

Table 91. GlaxoSmithKline Description and Business Overview

Table 92. GlaxoSmithKline Therapeutic Cancer Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 93. GlaxoSmithKline Therapeutic Cancer Vaccines Product

Table 94. GlaxoSmithKline Recent Developments/Updates

Table 95. Mayo Clinic Corporation Information

Table 96. Mayo Clinic Description and Business Overview

Table 97. Mayo Clinic Therapeutic Cancer Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 98. Mayo Clinic Therapeutic Cancer Vaccines Product

Table 99. Mayo Clinic Recent Developments/Updates

Table 100. Merck Corporation Information

Table 101. Merck Description and Business Overview

Table 102. Merck Therapeutic Cancer Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 103. Merck Therapeutic Cancer Vaccines Product

Table 104. Merck Recent Developments/Updates

Table 105. Moderna Corporation Information

Table 106. Moderna Description and Business Overview

Table 107. Moderna Therapeutic Cancer Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 108. Moderna Therapeutic Cancer Vaccines Product

Table 109. Moderna Recent Developments/Updates

Table 110. Northwest Biotherapeutics Corporation Information

Table 111. Northwest Biotherapeutics Description and Business Overview

Table 112. Northwest Biotherapeutics Therapeutic Cancer Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 113. Northwest Biotherapeutics Therapeutic Cancer Vaccines Product

Table 114. Northwest Biotherapeutics Recent Developments/Updates

Table 115. VAXIMM Corporation Information

Table 116. VAXIMM Description and Business Overview

Table 117. VAXIMM Therapeutic Cancer Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 118. VAXIMM Therapeutic Cancer Vaccines Product

Table 119. VAXIMM Recent Developments/Updates

Table 120. Key Raw Materials Lists

Table 121. Raw Materials Key Suppliers Lists

Table 122. Therapeutic Cancer Vaccines Distributors List

Table 123. Therapeutic Cancer Vaccines Customers List

Table 124. Therapeutic Cancer Vaccines Market Trends

Table 125. Therapeutic Cancer Vaccines Market Drivers

Table 126. Therapeutic Cancer Vaccines Market Challenges

Table 127. Therapeutic Cancer Vaccines Market Restraints

Table 128. Research Programs/Design for This Report

Table 129. Key Data Information from Secondary Sources

Table 130. Key Data Information from Primary Sources

List of Figures

Figure 1. Product Picture of Therapeutic Cancer Vaccines

Figure 2. Global Therapeutic Cancer Vaccines Market Value Comparison by Type (2024-2030) & (US$ Million)

Figure 3. Global Therapeutic Cancer Vaccines Market Share by Type in 2023 & 2030

Figure 4. Whole Cell Vaccine Product Picture

Figure 5. Antigen Vaccine Product Picture

Figure 6. Non-specific and Cytokine Strategies Product Picture

Figure 7. Others Product Picture

Figure 8. Global Therapeutic Cancer Vaccines Market Value Comparison by Application (2024-2030) & (US$ Million)

Figure 9. Global Therapeutic Cancer Vaccines Market Share by Application in 2023 & 2030

Figure 10. Bladder Cancer

Figure 11. Brain Tumors

Figure 12. Breast Cancer

Figure 13. Lung Cancer

Figure 14. Prostate Cancer

Figure 15. Cervical Cancer

Figure 16. Others

Figure 17. Global Therapeutic Cancer Vaccines Revenue, (US$ Million), 2019 VS 2023 VS 2030

Figure 18. Global Therapeutic Cancer Vaccines Market Size (2019-2030) & (US$ Million)

Figure 19. Global Therapeutic Cancer Vaccines Sales (2019-2030) & (K Units)

Figure 20. Global Therapeutic Cancer Vaccines Average Price (US$/Unit) & (2019-2030)

Figure 21. Therapeutic Cancer Vaccines Report Years Considered

Figure 22. Therapeutic Cancer Vaccines Sales Share by Manufacturers in 2023

Figure 23. Global Therapeutic Cancer Vaccines Revenue Share by Manufacturers in 2023

Figure 24. The Global 5 and 10 Largest Therapeutic Cancer Vaccines Players: Market Share by Revenue in 2023

Figure 25. Therapeutic Cancer Vaccines Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2019 VS 2023

Figure 26. Global Therapeutic Cancer Vaccines Market Size by Region (US$ Million): 2019 VS 2023 VS 2030

Figure 27. North America Therapeutic Cancer Vaccines Sales Market Share by Country (2019-2030)

Figure 28. North America Therapeutic Cancer Vaccines Revenue Market Share by Country (2019-2030)

Figure 29. U.S. Therapeutic Cancer Vaccines Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 30. Canada Therapeutic Cancer Vaccines Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 31. Europe Therapeutic Cancer Vaccines Sales Market Share by Country (2019-2030)

Figure 32. Europe Therapeutic Cancer Vaccines Revenue Market Share by Country (2019-2030)

Figure 33. Germany Therapeutic Cancer Vaccines Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 34. France Therapeutic Cancer Vaccines Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 35. U.K. Therapeutic Cancer Vaccines Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 36. Italy Therapeutic Cancer Vaccines Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 37. Russia Therapeutic Cancer Vaccines Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 38. Asia Pacific Therapeutic Cancer Vaccines Sales Market Share by Region (2019-2030)

Figure 39. Asia Pacific Therapeutic Cancer Vaccines Revenue Market Share by Region (2019-2030)

Figure 40. China Therapeutic Cancer Vaccines Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 41. Japan Therapeutic Cancer Vaccines Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 42. South Korea Therapeutic Cancer Vaccines Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 43. India Therapeutic Cancer Vaccines Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 44. Australia Therapeutic Cancer Vaccines Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 45. Taiwan Therapeutic Cancer Vaccines Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 46. Indonesia Therapeutic Cancer Vaccines Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 47. Thailand Therapeutic Cancer Vaccines Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 48. Malaysia Therapeutic Cancer Vaccines Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 49. Philippines Therapeutic Cancer Vaccines Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 50. Latin America Therapeutic Cancer Vaccines Sales Market Share by Country (2019-2030)

Figure 51. Latin America Therapeutic Cancer Vaccines Revenue Market Share by Country (2019-2030)

Figure 52. Mexico Therapeutic Cancer Vaccines Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 53. Brazil Therapeutic Cancer Vaccines Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 54. Argentina Therapeutic Cancer Vaccines Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 55. Middle East & Africa Therapeutic Cancer Vaccines Sales Market Share by Country (2019-2030)

Figure 56. Middle East & Africa Therapeutic Cancer Vaccines Revenue Market Share by Country (2019-2030)

Figure 57. Turkey Therapeutic Cancer Vaccines Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 58. Saudi Arabia Therapeutic Cancer Vaccines Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 59. UAE Therapeutic Cancer Vaccines Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 60. Global Sales Market Share of Therapeutic Cancer Vaccines by Type (2019-2030)

Figure 61. Global Revenue Market Share of Therapeutic Cancer Vaccines by Type (2019-2030)

Figure 62. Global Therapeutic Cancer Vaccines Price (US$/Unit) by Type (2019-2030)

Figure 63. Global Sales Market Share of Therapeutic Cancer Vaccines by Application (2019-2030)

Figure 64. Global Revenue Market Share of Therapeutic Cancer Vaccines by Application (2019-2030)

Figure 65. Global Therapeutic Cancer Vaccines Price (US$/Unit) by Application (2019-2030)

Figure 66. Therapeutic Cancer Vaccines Value Chain

Figure 67. Therapeutic Cancer Vaccines Production Process

Figure 68. Channels of Distribution (Direct Vs Distribution)

Figure 69. Distributors Profiles

Figure 70. Bottom-up and Top-down Approaches for This Report

Figure 71. Data Triangulation

Figure 72. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions